Assignee
SYMPHOGEN AS
DK17 patents
Top patents by PatentIndex Score
US7887805B2Feb 15, 2011
Recombinant anti-epidermal growth factor receptor antibody compositions
SYMPHOGEN AS56 citations95
US7749697B2Jul 6, 2010
Method for linking sequences of interest
SYMPHOGEN AS134 citations91
US7850965B2Dec 14, 2010
Anti-orthopoxvirus recombinant polyclonal antibody
SYMPHOGEN AS36 citations88
US6849259B2Feb 1, 2005
Polyclonal antibody composition for treating allergy
SYMPHOGEN AS97 citations88
US11034765B2Jun 15, 2021
Anti-PD-1 antibodies and compositions
SYMPHOGEN AS17 citations80
US10058610B2Aug 28, 2018
Methods for treating cancer by administering humanized pan-HER antibody compositions
SYMPHOGEN AS9 citations80
US7910332B2Mar 22, 2011
Method for manufacturing a recombinant polyclonal protein
SYMPHOGEN AS9 citations77
US7879329B2Feb 1, 2011
Recombinant antibodies for treatment of respiratory syncytial virus infections
SYMPHOGEN AS13 citations76
US11390674B2Jul 19, 2022
Anti-TIM-3 antibodies and compositions
SYMPHOGEN AS4 citations69
US10221246B2Mar 5, 2019
Pan-HER antibody composition
SYMPHOGEN AS2 citations69
US9527913B2Dec 27, 2016
Humanized pan-HER antibody compositions
SYMPHOGEN AS4 citations69
US11390676B2Jul 19, 2022
Anti-LAG-3 antibodies and compositions
SYMPHOGEN AS3 citations68
US11359018B2Jun 14, 2022
Anti-PD-1 antibodies and compositions
SYMPHOGEN AS2 citations68
US11939380B2Mar 26, 2024
Combination therapies targeting PD-1, TIM-3, and LAG-3
SYMPHOGEN AS1 citations57
US11807688B2Nov 7, 2023
Anti-AXL antibodies and compositions
SYMPHOGEN AS0 citations53
US10450376B2Oct 22, 2019
Anti-MET antibodies and compositions
SYMPHOGEN AS0 citations43
US9029091B2May 12, 2015
Procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line
SYMPHOGEN AS0 citations41